Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001781002-24-000050
Filing Date
2024-10-07
Accepted
2024-10-07 17:07:34
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 8443
2 SUBSIDIARY INFORMATION (322) ex99-1.htm EX-99 783
  Complete submission text file 0001781002-24-000050.txt   10973
Mailing Address 40 GUEST STREET BOSTON MA 02135
Business Address 40 GUEST STREET BOSTON MA 02135 617-949-2680
Cue Biopharma, Inc. (Subject) CIK: 0001645460 (see all company filings)

EIN.: 473324577 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-90232 | Film No.: 241358561
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 1345 AVENUE OF THE AMERICAS 47TH FLOOR NEW YORK NY 10105
Business Address 1345 AVENUE OF THE AMERICAS 47TH FLOOR NEW YORK NY 10105 917-769-2999
Bleichroeder LP (Filed by) CIK: 0001781002 (see all company filings)

EIN.: 842006600 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A